Carlos Cheruiyot

Carlos Cheruiyot

Auto-generated profile, based on publicly available information

Carlos Cheruiyot

Kenyatta University

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 October 2025 in medRxiv
Verified
Preprint
Open access
PDF file
CCCarlos Cheruiyot
Carlos Cheruiyot
PKPeter Kaberia
Peter Kaberia
WNWalter Nyagah
Walter Nyagah
JKJames Kang’ethe
James Kang’ethe
ASAdrian D. Smith
Adrian D. Smith
SMSamuel Waweru Mwaniki
Samuel Waweru Mwaniki
Despite availability of highly effective oral HIV pre-exposure prophylaxis (PrEP) for close to a decade, uptake and adherence among at-risk young men who have sex with men (YMSM) in Kenya, remain significantly low. This study investigated levels of PrEP knowledge, motivations, facilitators and barriers influencing PrEP initiation, persistence and adherence among YMSM, in efforts to optimise use and reduce risk of new HIV infections. In September 2021, 22 YMSM purposively selected from 248 YMSM who had previously participated in an integrated bio-behavioural sexual health survey, took part in semi-structured in-depth interviews. Interview guides were developed based on the Information-Motivation-Behavioural skills (IMB) model. Questions focused on each of the three IMB model constructs: information about PrEP, motivational factors influencing decision to use or not to use PrEP, and ability to initiate and adhere to PrEP. Data analysis generated three key themes: knowledge, motivation, and barriers to using oral and on-demand PrEP. Participants expressed its awareness and effectiveness in HIV prevention, but were concerned about PrEP- and HIV-related stigma, with the fear that family, friends, and potential romantic partners might perceive them as being promiscuous, or as living with HIV. Participants reported being capable of seeking PrEP services provided in MSM-friendly facilities, with public health facilities perceived as hostile considering the criminalization of, and societal stigma toward same-sex practices. These findings highlight the crucial need to re-strategize PrEP promotion not only as an effective but also a safe HIV-prevention option for at-risk populations. This study recommends expediting the integration of long acting lenacapavir and cabotegravir in the Kenyan health system as a means to diversify PrEP modalities and potentially reduce the stigma experienced in oral PrEP use.

16 July 2026 in PLOS Global Public Health
Verified
Journal Article
Open access
PDF file
CCCarlos Cheruiyot
Carlos Cheruiyot
PKPeter Kaberia
Peter Kaberia
WNWalter Nyagah
Walter Nyagah
JKJames Kang’EThe
James Kang’EThe
ASAdrian D. Smith
Adrian D. Smith
SMSamuel Waweru Mwaniki
Samuel Waweru Mwaniki
Despite availability of highly effective oral HIV pre-exposure prophylaxis (PrEP) for close to a decade, uptake and adherence among at-risk young men who have sex with men (YMSM) in Kenya, remain significantly low. This study investigated levels of PrEP knowledge, motivations, facilitators and barriers influencing PrEP initiation, persistence and adherence among YMSM, in efforts to optimise use and reduce risk of new HIV infections. In September 2021, 22 YMSM selected from 248 YMSM who had previously participated in an integrated bio-behavioural sexual health survey, took part in semi-structured in-depth interviews. Data analysis generated three key categories informed by the Information-Motivation-Behavioural skills (IMB) model: knowledge, motivation, and barriers influencing the use of oral and on-demand PrEP. Participants expressed PrEP awareness and effectiveness in HIV prevention, but were concerned about PrEP- and HIV-related stigma, with the fear that family, friends, and potential romantic partners might perceive them as being promiscuous, or as living with HIV. Participants reported being capable of seeking PrEP services provided in MSM-friendly facilities, with public health facilities perceived as hostile considering the criminalisation of, and societal stigma toward same-sex practices. These findings highlight the crucial need to re-strategise PrEP promotion not only as an effective but also a safe HIV-prevention option for at-risk populations. This study recommends expediting the integration of long acting lenacapavir and cabotegravir in the Kenyan health system as a means to diversify PrEP modalities and potentially reduce the stigma experienced in oral PrEP use.

14 September 2026 in medRxiv
Verified
Preprint
Open access
PDF file
SMSamuel Waweru Mwaniki
Samuel Waweru Mwaniki
RKRichard M. Kilonzo
Richard M. Kilonzo
PKPeter Kaberia
Peter Kaberia
CCCarlos K. Cheruiyot
Carlos K. Cheruiyot
WNWalter M. Nyagah
Walter M. Nyagah
TPThesla Palanee-Phillips
Thesla Palanee-Phillips
Mental health conditions among young sexual minority men (YSMM) are a growing public health concern, yet they are understudied in sub-Saharan African settings. We aimed to estimate the prevalence of depressive and anxiety symptoms, and associated factors among YSMM in Kenya. Between February and March 2021, we conducted a cross-sectional bio-behavioral survey among YSMM aged 18 years or older and enrolled in tertiary academic institutions in Nairobi, using respondent-driven sampling. Participants completed an electronically self-administered demographic and behavioral questionnaire on REDCap. Depressive and anxiety symptoms were assessed using Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) tools respectively, with scores equal to or greater than 10 indicating moderate-to-severe symptoms. HIV antibody testing followed Kenyan national guidelines. Principal component analysis was used to derive stigma-related domains, and multivariate logistic regression identified factors associated with outcomes. Data analysis was done using Stata v.17 software. Among 242 participants, median age was 21 years (IQR 19-23). Prevalence of depressive, anxiety, co-occurring depressive/anxiety symptoms and HIV were: 23.7% (95% CI: 18.4-29.5), 16.9% (95% CI: 12.4-22.3), 12.4% (95% CI: 8.5-17.2) and 8.3% (95% CI: 5.1-12.5), respectively. Factors independently associated with depressive symptoms were: living with HIV (AOR: 4.88, 95% CI: 1.18-20.18, p = 0.029), moderate-to-severe anxiety symptoms (AOR: 25.63, 95% CI: 8.58-76.61, p<0.001), healthcare-related discrimination (AOR: 1.56, 95% CI: 1.07-2.28, p = 0.020) and early years of study (AOR: 2.79, 95% CI: 1.09-7.15, p = 0.033). Factors independently associated with anxiety symptoms were: moderate-to-severe depressive symptoms (AOR: 26.10, 95% CI: 8.10-84.15, p <0.001), attending a public academic institution (AOR: 3.33, 95% CI: 1.14-10.00, p = 0.028), and boarding school history (AOR: 4.35, 95% CI: 1.14-16.67, p = 0.032). YSMM in Nairobi experience a high burden of depressive and anxiety symptoms with substantial co-occurrence. Living with HIV, experiencing healthcare-related discrimination and educational context play key roles in shaping mental health outcomes among YSMM. These findings underscore the importance of integrating mental health with HIV services, alongside stigma-reduction interventions in both healthcare and educational settings, to improve access, quality of care, and outcomes for this young key population.

Verified
Open access
PDF file
CCCarlos Cheruiyot
Carlos Cheruiyot
PKPeter Kaberia
Peter Kaberia
WNWalter Nyagah
Walter Nyagah
JKJames Kang’Ethe
James Kang’Ethe
ASAdrian D. Smith
Adrian D. Smith
SMSamuel Waweru Mwaniki
Samuel Waweru Mwaniki
Despite availability of highly effective oral HIV pre-exposure prophylaxis (PrEP) for close to a decade, uptake and adherence among at-risk young men who have sex with men (YMSM) in Kenya, remain significantly low. This study investigated levels of PrEP knowledge, motivations, facilitators and barriers influencing PrEP initiation, persistence and adherence among YMSM, in efforts to optimise use and reduce risk of new HIV infections. In September 2021, 22 YMSM selected from 248 YMSM who had previously participated in an integrated bio-behavioural sexual health survey, took part in semi-structured in-depth interviews. Data analysis generated three key categories informed by the Information-Motivation-Behavioural skills (IMB) model: knowledge, motivation, and barriers influencing the use of oral and on-demand PrEP. Participants expressed PrEP awareness and effectiveness in HIV prevention, but were concerned about PrEP- and HIV-related stigma, with the fear that family, friends, and potential romantic partners might perceive them as being promiscuous, or as living with HIV. Participants reported being capable of seeking PrEP services provided in MSM-friendly facilities, with public health facilities perceived as hostile considering the criminalisation of, and societal stigma toward same-sex practices. These findings highlight the crucial need to re-strategise PrEP promotion not only as an effective but also a safe HIV-prevention option for at-risk populations. This study recommends expediting the integration of long acting lenacapavir and cabotegravir in the Kenyan health system as a means to diversify PrEP modalities and potentially reduce the stigma experienced in oral PrEP use.

Verified
Open access
PDF file
CCCarlos Cheruiyot
Carlos Cheruiyot
PKPeter Kaberia
Peter Kaberia
WNWalter Nyagah
Walter Nyagah
JKJames Kang’Ethe
James Kang’Ethe
ASAdrian D. Smith
Adrian D. Smith
SMSamuel Waweru Mwaniki
Samuel Waweru Mwaniki
Despite availability of highly effective oral HIV pre-exposure prophylaxis (PrEP) for close to a decade, uptake and adherence among at-risk young men who have sex with men (YMSM) in Kenya, remain significantly low. This study investigated levels of PrEP knowledge, motivations, facilitators and barriers influencing PrEP initiation, persistence and adherence among YMSM, in efforts to optimise use and reduce risk of new HIV infections. In September 2021, 22 YMSM selected from 248 YMSM who had previously participated in an integrated bio-behavioural sexual health survey, took part in semi-structured in-depth interviews. Data analysis generated three key categories informed by the Information-Motivation-Behavioural skills (IMB) model: knowledge, motivation, and barriers influencing the use of oral and on-demand PrEP. Participants expressed PrEP awareness and effectiveness in HIV prevention, but were concerned about PrEP- and HIV-related stigma, with the fear that family, friends, and potential romantic partners might perceive them as being promiscuous, or as living with HIV. Participants reported being capable of seeking PrEP services provided in MSM-friendly facilities, with public health facilities perceived as hostile considering the criminalisation of, and societal stigma toward same-sex practices. These findings highlight the crucial need to re-strategise PrEP promotion not only as an effective but also a safe HIV-prevention option for at-risk populations. This study recommends expediting the integration of long acting lenacapavir and cabotegravir in the Kenyan health system as a means to diversify PrEP modalities and potentially reduce the stigma experienced in oral PrEP use.

Verified
Open access
PDF file
CCCarlos Cheruiyot
Carlos Cheruiyot
PKPeter Kaberia
Peter Kaberia
WNWalter Nyagah
Walter Nyagah
JKJames Kang’Ethe
James Kang’Ethe
ASAdrian D. Smith
Adrian D. Smith
SMSamuel Waweru Mwaniki
Samuel Waweru Mwaniki
Despite availability of highly effective oral HIV pre-exposure prophylaxis (PrEP) for close to a decade, uptake and adherence among at-risk young men who have sex with men (YMSM) in Kenya, remain significantly low. This study investigated levels of PrEP knowledge, motivations, facilitators and barriers influencing PrEP initiation, persistence and adherence among YMSM, in efforts to optimise use and reduce risk of new HIV infections. In September 2021, 22 YMSM selected from 248 YMSM who had previously participated in an integrated bio-behavioural sexual health survey, took part in semi-structured in-depth interviews. Data analysis generated three key categories informed by the Information-Motivation-Behavioural skills (IMB) model: knowledge, motivation, and barriers influencing the use of oral and on-demand PrEP. Participants expressed PrEP awareness and effectiveness in HIV prevention, but were concerned about PrEP- and HIV-related stigma, with the fear that family, friends, and potential romantic partners might perceive them as being promiscuous, or as living with HIV. Participants reported being capable of seeking PrEP services provided in MSM-friendly facilities, with public health facilities perceived as hostile considering the criminalisation of, and societal stigma toward same-sex practices. These findings highlight the crucial need to re-strategise PrEP promotion not only as an effective but also a safe HIV-prevention option for at-risk populations. This study recommends expediting the integration of long acting lenacapavir and cabotegravir in the Kenyan health system as a means to diversify PrEP modalities and potentially reduce the stigma experienced in oral PrEP use.